Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action

Type 2 diabetes is a syndrome characterized by relative insulin deficiency, insulin resistance and increased hepatic glucose output. Medications used to treat the disease are designed to correct one or more of these metabolic abnormalities. Current recommendations of the American Diabetes Associatio...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Graziella Bruno, Bartolomeo Lorenzati, Chiara Zucco, Sara Miglietta, Federico Lamberti
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI AG 2010-09-01
Reeks:Pharmaceuticals
Onderwerpen:
hypoglycemic drugs
sulfonylureas
thiazolidinediones
incretin mimeticshypoglycemic drugs
incretin mimetics
Online toegang:http://www.mdpi.com/1424-8247/3/9/3005/
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items